NCT00592072View on ClinicalTrials.gov

Effect of Medium Chain Fatty Acids on Cognitive Function During Acute Hypoglycemia in Patients With Type 1 Diabetes

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions
Diabetes Mellitus, Type 1
Interventions
DIETARY_SUPPLEMENT

Medium chain fatty acid (Octanoic and Decanoic acid)

Octanoic acid(67%) and Decanoic acid (27%); MCFA 50g total at 25 minute intervals with front loading of 20g then 10g for three administrations.

OTHER

Splenda (Placebo Control)

Placebo drink will consist of dietary sweetener Splenda mixed in water at a concentration of 1g/100mL. An unsweetened cherry flavor Koolaid mix will be added at a concentration of 0.3g/100mL of the Splenda drink to enhance flavor.

Trial Locations (1)

06520

Yale University School of Medicine, New Haven

Sponsors
All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

collaborator

Juvenile Diabetes Research Foundation

OTHER

lead

Yale University

OTHER